ArticleFrontiers in pharmacology2026

Optimal buprenorphine exposure to treat patients with opioid use disorder in the era of fentanyl and polysubstance use.

L R L Lohmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.